PXL/HO/Cir-090/2022-23 Date: 05.01.2023
SUBJECT: Request for Inputs on Market Access Issues while exporting to ASEAN
In order to examine market impediments that companies face and to take appropriate actions to increase exports to regions with export potential, the EP (Pharma) Division of Department of Commerce, in coordination with PHARMEXCIL will engage with Indian exporters in the coming weeks.
The ASEAN region is fifth largest in terms of exports and identified as one of the regions with high export potential by the EP (Pharma) division. Countries of Focus in ASEAN are as follows: (1) Singapore, (2) Indonesia, (3) Malaysia, (4) Myanmar & (5) Brunei.
Companies are requested to kindly submit the Market Impediments being faced by them while exporting to the above-mentioned countries in the Google Form (https://forms.gle/cKk8hBYVg1hmMnAW7).
If no information is available, kindly fill in the blank with N/A to go to the next section. Given the time bound nature of this activity, it is requested to kindly complete the form by 9th January 2023.